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Lumbar disc herniation (LDH) is a major cause of discogenic low back pain and sciatica, but the underlying
mechanisms remain largely unknown. Hydrogen sulfide (H2S) is becoming recognized for its involvement in a wide
variety of processes including inflammation and nociception. The present study was designed to investigate the
roles of the H2S signaling pathway in the regulation of expression and function of purinergic receptors (P2XRs) in
dorsal root ganglion (DRG) neurons from rats with LDH. LDH was induced by implantation of autologous nucleus
pulposus (NP), harvested from rat tail, in lumbar 5 and 6 spinal nerve roots. Implantation of autologous NP induced
persistent pain hypersensitivity, which was partially reversed by an intrathecal injection of A317491, a potent
inhibitor of P2X3Rs and P2X2/3Rs. The NP induced persistent pain hypersensitivity was associated with the
increased expression of P2X3Rs, but not P2X1Rs and P2X2Rs, receptors in L5-6 DRGs. NP implantation also produced
a 2-fold increase in ATP-induced intracellular calcium signals in DRG neurons when compared to those of controls
(P < 0.05). Interestingly, NP implantation significantly enhanced expression of the endogenous hydrogen sulfide
producing enzyme, cystathionine-β-synthetase (CBS). Systematic administration of O-(Carboxymethyl) hydroxylamine
hemihydrochloride (AOAA), an inhibitor of CBS, suppressed the upregulation of P2X3R expression and the potentiation
of ATP-induced intracellular calcium signals in DRG neurons (P < 0.05). Intrathecal injection of AOAA markedly
attenuated NP induced- persistent pain hypersensitivity. Our results suggest that sensitization of P2X3Rs, which
is likely mediated by CBS-H2S signaling in primary sensory neurons, contributes to discogenic pain. Targeting
CBS/H2S-P2X3R signaling may represent a potential treatment for neuropathic pain caused by LDH.
Keywords: Lumbar disc herniation, Dorsal root ganglion, Neuropathic pain, Hydrogen sulfide, P2X receptorsIntroduction
Lumbar disc herniation (LDH) is one of the most com-
mon causes of discogenic low back pain and sciatica in
clinical settings. Symptoms in patients are induced by
both mechanical compression and chemical inflamma-
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unless otherwise stated.sensory neurons in the associated dorsal root ganglia
(DRGs) are affected by mechanical and chemical injury.
Inflammatory reactions between nucleus pulposus (NP)
and the nerve roots have been suggested to play an import-
ant role in disc herniation with sciatica [1-5]. Experimental
studies have demonstrated that epidural application of NP
leads to pronounced morphologic and functional changes
in the nerve roots [6-9]. However, the pathogenic mecha-
nisms linking herniated NP, gene expression, and pain
hypersensitivity are not well understood.
Purinergic P2X receptors (P2XRs), which are ligand-
gated cation channels, are preferentially expressed in
DRG neurons and have been implicated in inflammatoryThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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neuropathic pain [12-14]. Emerging evidence has sug-
gested that the P2X3R plays an important role in im-
mune responses and inflammatory diseases. Recently,
many studies have confirmed that this receptor is also
involved in the development of neuropathic pain
[15-18]. Recent reports have shown an increase in
P2X3R expression in primary sensory afferents [19,20].
In addition, local application of nucleus pulposus in-
duces expression of P2X3Rs in rat dorsal root ganglion
cells [9], suggesting a role for P2X3Rs in disc herniation
and sciatica. However, the mechanism underlying P2X3R
upregulation under LDH conditions remains largely
unknown.
Hydrogen sulfide (H2S), synthesized by the endo-
genous enzymes cystathionine-β-synthetase (CBS) and
cystathionine-γ-lyase (CSE), is increasingly recognized
as a biologically important signaling molecule in vari-
ous tissues and pathophysiological processes, includ-
ing pain and inflammation [21-24]. Its putative role
as a neurotransmitter/modulator is supported by re-
cent reports on its effects on hippocampal neurons as
well as peripheral sensory neurons [24-27]. With re-
spect to the latter, intraplantar injection of NaHS (a
commonly used H2S donor) in rat hindpaws produces
mechanical hyperalgesia through activation of T-type
Ca2+ channels, supporting a pro-nociceptive role for
H2S [25]. H2S generation is enhanced in formalin [26] and
carrageenan [28] models of persistent inflammatory
pain. Colonic administration of H2S enhances pain
behaviors in response to CRD in mice [22] and rats
[17]. A growing body of evidence indicates a role for
the CBS-H2S signaling pathway in inflammatory and
neuropathic pain conditions. However, the role of CBS-
H2S signaling in discogenic neuropathic pain hypersensi-
tivity is unknown.
Our aim was therefore to study the potential role
of H2S in the pathogenesis of sciatica hyperalgesia in
a well-characterized rat model of lumbar disc hernia-
tion. In particular, we investigated whether the CBS-
H2S and P2X3R signaling pathways were involved in
discogenic neuropathic pain. We hypothesized that
P2X3 receptors activated by the CBS-H2S signaling
pathway participate in discogenic mechanical allody-
nia. To test this hypothesis, we investigated the roles
of CBS and P2X3Rs in DRGs in LDH rats and a
sham group of rats. Our results indicate that NP-
induced peripheral discogenic pain hypersensitivity is
likely mediated by upregulation of P2X3R expression
in DRGs, and that CBS produces pronociceptive ef-
fects via activation of the CBS-H2S-P2X3R signaling
pathway. These results may enhance our understand-
ing of pathophysiological mechanisms associated with
disc herniation and sciatica.Methods and materials
Animals
The Institutional Animal Care and Use Committee of
Soochow University specifically approved this study.
Experiments were performed on adult male Sprague–
Dawley rats (220 ± 20 g). Animals were housed under
controlled conditions (07:00 ~ 19:00 lighting, 24 ± 2°C)
with free access to a standard laboratory diet and fresh
water. Care and handling of rats were provided to
ameliorate suffering in accordance with the guidelines
of the International Association for the Study of Pain.
In the present study, most experiments were performed
7 days after NP application, unless otherwise indicated.
We selected this time point to perform experiments be-
cause the paw withdraw threshold was at the lowest
point on the time-response curve (Figure 1A) and also to
minimize the suffering of rats from pain hypersensitivity.
Disc herniation model
Surgeries for the disc herniation model were performed
as described in detail previously [22,29,30]. In brief,
animals were divided into NP-treated and sham groups.
All experimental procedures were performed on rats
that were deeply anesthetized with sodium pentobarbital
(50 mg/kg body weight, intraperitoneally). Additional
doses of the anesthetics were administered as needed.
The hair of rat’s lower back was shaved, and the skin
was sterilized with 0.5% chlorhexidine and covered with
clean paper. Sterile operating instruments were used. NP
was harvested from the disc level between the second
and third coccygeal intervertebral disc of each tail. To
expose the lumbar 5 and lumbar 6 nerve roots, a midline
dorsal incision from L4 to S1 was made over the lumbar
spine. Harvested NP (approximately 5 mg) was implanted
next to the left L5 and L6 nerve roots just proximal to
the corresponding DRG. The amount of NP was applied
approximately equally among rats. The right side of the
dorsal roots was left intact without surgery in all rats.
Special care was taken to minimize the mechanical
compression at the time of surgery and prevent infec-
tion and minimize the influence of inflammation. The
surgical procedure for the sham control group was
identical to the NP treated group, including harvesting
autologous NP from each rat tail and exposing nerve
roots, but implantation of the autologous NP was omitted.
After surgery, the rats were housed in individual cages in
the animal room until they fully recovered.
Pain behavior test
Rats (NP-treated group, n = 8, sham group n = 8) were
tested for mechanical sensitivity of the plantar surface of
the hindpaws 3 days before surgery and 3, 7, 14, 21, 28
and 35 days after surgery by an investigator blinded to
the experimental group and protocol.
Figure 1 Antagonism of P2X3 receptors on discogenic pain behavior. (A) In rats treated with NP, the mechanical paw withdrawal threshold
(PWT) was decreased significantly on the ipsilateral side at 3, 7, 14, 21 and 28 days after surgery compared to the sham group (*P < 0.05, n = 11
for the LDH group and n = 8 for the sham group). (B) In rats treated with NP, the body weight bearing difference was dramatically increased between
hindlimbs at 3, 7, 14, 21 and 28 days after surgery compared to the sham group (*P < 0.05, n = 7 for the LDH group and n = 6 for the sham group).
(C) Compared to the sham group, NP-application did not produce any effect on time to fall for rats on the Rota rod (n = 8 for each group, P > 0.05).
(D) Administration of the P2X3R inhibitor A317491 mitigated mechanical hyperalgesia in LDH rats. The A317491-induced antinociceptive effects were
observed at 30 min and disappeared 4 hours after a single intrathecal (it) injection of A317491 at the doses of 30,100 and 300 nmol. n = 6 rats for each
group, *P < 0.05, **P < 0.01 compared to the NS group. (E) Administration of the P2X3R inhibitor A317491 reduced the body weight bearing difference
induced by LDH. The A317491-induced antinociceptive effect disappeared 4 hours after a single intrathecal (it) injection of A317491 at doses of 30,100
and 300 nmol; n = 6 rats for each group *P < 0.05, compared to Pre injection values. (F) Administration of A317491 (it) did not produce any effect on
PWT in healthy control rats (n = 5, P > 0.05). (G) Administration of A317491 (it) did not produce any effect on the time to fall for LDH rats in the Rota
rod test (n = 8).
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Changes in hind paw mechanical withdrawal thresholds
(PWT) were assessed utilizing von Frey filaments (VFF)
as previously described [27,31-33]. A series of calibrated
von Frey filaments (0.55, 0.93, 1.61, 1.98, 2.74, 4.87, 7.37,
11.42, 15.76, and 20.30) were applied perpendicularly to
the plantar surface of the rat hind paw with sufficient force
to bend the filaments for 60 s or until the rat withdrew. In
the presence of a response, a filament of the next greater
force was applied. In the absence of a response, a filament
of the next lower force was applied. To avoid the potential
injury, the cutoff strength of von Frey filaments was set at
20.30 g. The tactile stimulus producing a 50% likelihood
of withdrawal was determined by the “up-down” calculat-
ing method, as described in detail previously [27,31-33].
Each test was repeated 2–3 times at approximately 2-min
intervals, and the average value of VFF force was used as
the force to evoke a withdrawal response.Body weight-bearing by the hind limbs
Hindlimb body weight-bearing differences were mea-
sured using an incapacitance tester (PH-200, Taimeng
Chengdu, CHN). Measurements were recorded as aver-
ages of three trials, with each trial measuring the weight
over 5 s. Weight-bearing is presented as weight on the
contralateral limb - weight on the ipsilateral limb and
weight-bearing asymmetry is indicative of hyperalgesia.
Rats were tested on days 0 and 3–35 post-implantation.
Western blotting
The protocols for western blotting were described previ-
ously by us [33-36]. In brief, lumbar DRGs (L5-6) from
the ipsilateral side of the spinal cord were quickly dis-
sected out and frozen in liquid nitrogen. Protein ex-
tracted from ipsilateral (L5-6) DRGs of NP-treated and
sham rats were prepared in MT-CelLytics mammalian
tissue protein extraction reagent with 1 mM PIC (1:100
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& Technology Company, CHN). Twenty micrograms of
proteins were fractionated on 10% polyacrylamide gels
(Bio-Rad) and then transferred to polyvinyl difluoride
(PVDF) membranes (Roche) at 200 mA for 2 hours at 4°C.
After membranes were blocked for 2 hours in TBS (50
mM Tris-Base, 133 mM NaCl, pH = 7.4) and a 5% dilu-
tion of non-fat milk powder, they were incubated with
primary antibodies (mouse anti-CBS, anti-CSE Abnova
Taiwan, CHN at 1:1000 and rabbit anti-P2X3R at 1:1000,
anti-P2X1R and anti-P2X2R at 1:1000 Alomone, Israel)
for 2 hours in 1% milk and TBS at room temperature.
After washing in TBST (0.5% Tween-20 in TBS), the
PVDF membranes were incubated with HRP conjugated
secondary antibodies (1:4000, MultiSciences Biotech Co.,
CHN) in TBS and 1% milk for 2 hours at room
temperature. Bands were visualized using ECL (Biological
Industries, CHN) and exposed to Kodak X-ray films.
Membranes were subsequently stripped and re-probed for
GAPDH (1:1000, Hangzhou Goodhere Biotechnology Co.,
CHN). Films were scanned and band intensities were de-
termined using Optic Quant software (ImageJ, NIH). CBS,
CSE, P2X1, P2X2 and P2X3 receptor data were expressed
as values normalized to GAPDH levels.
Immunofluorescence study
As described previously [36], rats were deeply anesthe-
tized one week after DiI injection. Animals were then
perfused transcardially with 150 ml PBS followed by 400
ml ice-cold 4% paraformaldehyde in PBS. DRGs (L5 and
L6) were removed and postfixed for 1 hour in para-
formaldehyde and cryoprotected overnight with 20%
sucrose in PBS. To ensure that a neuron was counted
only once, serial sections were placed on consecutive
slides with at least 50 μm between sections on the same
slide. For triple labeling, 10 μm sections were simultan-
eously incubated with P2X3R (1:1000) and CBS (1:200)
antibodies and then incubated with Alexa Fluor 488 and
355. The negative control was employed by omitting the
primary antibody. Sections were viewed with filter cubes
appropriate for DiI (rhodamine filter), Alexa 488 and
Alexa 355. Images were captured and analyzed using
Metaview software as described in detail previously [36].
Rota rod analysis
The Rota rod system (ZH-300, Zhenghua, Anhui Province,
CHN) for locomotor assessment was used to measure
the time period for an animal to maintain its balance on
a moving cylinder [37,38]. Animals were first condi-
tioned on a stationary rod for 30 s, and during this time,
animals that fell off the cylinder were placed back on
the Rota rod. Next, the animals were conditioned at a
constant speed of 20 rpm for a period of 300 s. Animals
that failed the first conditioning period were allowedtwo additional periods, and those that failed the third
conditioning period were omitted from further testing.
This assured that all animals in all treatment groups
attained an analogous baseline. The baseline values
were 290.7 ± 3.4 seconds (n = 8) and 293.5 ± 3.5
seconds (n = 8) for sham and LDH, respectively. The
same basic conditioning methodology was employed in
the NP and sham groups. Thirty minutes after the last
conditioning, each animal was placed on the Rota rod
and its latency until falling was determined and expressed
in seconds (s).
Cell retrograde labeling
The origin of the primary afferent innervation of the sci-
atic nerve was determined by retrograde tracing using
1,19-dioleyl-3,3,39,3-tetramethylindocarbocyanine metha-
nesulfonate (DiI, Invitrogen, Carlsbad, CA). Experi-
ments were performed on male SD rats (200 ~ 220
grams, n = 20) as described in detail previously [34,35,39].
In brief, animals were anesthetized with chloral hydrate
(360 mg/kg). Then, DiI (25 mg in 0.5 ml methanol) was
slowly injected in 10 μL volumes into the left hindpaw at
five different points (2 μl in each point) using a micro-
injection syringe after NP application or sham operation.
The syringe was left in place for an additional 2 min to
prevent the DiI from leaking out along the injection track.
One week later, lumbar L5-6 DRGs were dissected out for
the calcium imaging study or immunofluorescence study.
Dissociation of DRG neurons and calcium imaging
The isolation of DRG neurons was performed 7 days
after NP application or sham operation as described in
detail previously [27,36]. In brief, animals were sacrificed
by cervical dislocation, followed by decapitation. DRGs
(L5-6) were then left ipsilaterally dissected out and
transferred to an ice-cold, oxygenated dissecting solu-
tion. The dissecting solution contained (in mM): 130
NaCl, 5 KCl, 2 KH2PO4, 1.5 CaCl2, 6 MgSO4, 10 glucose,
and 10 HEPES, pH 7.2 and osmolarity: 305 mOsm. After
removal of connective tissue, DRGs were incubated for
1 h at 34.5°C in the dissecting solution which contained
collagenase D (3.0 ~ 3.2 mg/ml, Roche; Indianapolis, IN)
and trypsin (1.5 mg/ml, Sigma; St. Louis, MO). The gan-
glia were then washed and transferred to the dissecting
solution containing DNase (0.5 mg/ml, Sigma, St. Louis,
MO). After repeated trituration through flame-polished
glass pipettes, a single-cell suspension was subsequently
obtained for calcium imaging studies.
DRG neurons were then loaded with fura-2 acetoxy-
methyl ester (2 μM; Invitrogen, Carlsbad, CA) for 30
min at 37°C in an atmosphere of 5% CO2. Fura-2 acetox-
ymethyl ester was dissolved in normal external solution to
which bovine serum albumin (5 mg/ml; Sigma-Aldrich)
was added to promote dye loading. Ca2+ imaging was
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erslips were placed on an inverted epifluorescence
microscope (IX70; Olympus, Tokyo, Japan) and con-
tinuously superfused with normal external solution.
Fura-2 was excited alternately with UV light at 340
and 380 nm, and the fluorescence emission was de-
tected at 510 nm using a computer-controlled mono-
chromator. Image pairs were acquired every 5 s to
30 s using illumination periods between 100 and 250
ms in duration. Wavelength selection and the timing
of excitation and acquisition of images were controlled
using the Metaflour program (Molecular Devices). Digital
images were stored for off-line analysis.
Drugs (ATP) were dissolved in external solution from
concentrated stock solutions and delivered via bath ap-
plication using a gravity-driven application system. A
stock solution of ATP (20 mM) was made in ultrapure
water and further diluted in normal external solution
to the final concentration (20 μM). Image analysis
was performed using the Metawave program. The
background was subtracted to minimize camera dark
noise and tissue autofluorescence. An area of interest
was drawn around each cell, and the average value
of all pixels included in this area was used as one
measurement. The ATP-induced intracellular calcium
mobilization was expressed as the ratio of the fluores-
cence signal measured at 340 nm to the fluorescence
signal measured at 380 nm. Amplitudes of peak [Ca2+]i
responses were computed as the difference between the
peak value and the baseline value. To be considered an
ATP-induced response, changes in [Ca2+]i had to occur
within 2 to 3 min after drug application, and the ampli-
tudes had to exceed baseline by 2 times the standard
deviation.
Drug application
AOAA (an inhibitor of CBS), A317491 (an antagonist of
the P2X3 receptor), and ATP were purchased from
Sigma-Aldrich and were freshly prepared in 0.9% normal
saline. AOAA was intrathecally injected once daily for 7
consecutive days for molecular expression experiments
and behavioral tests. A317491 was administered by a
single intrathecal injection for behavioral tests.
Data analysis
Data are expressed as mean ± standard error. Statistical
analyses were performed using OriginPro 8 (OriginLab,
US) and Matlab softwares (Mathworks, US). Normality
was verified for all data before analyses. Significance was
determined by the use of a two sample t-test, Kruskal-
Wallis ANOVA followed by Tukey’s post hoc test, one-
way or two-way repeated-measures ANOVA followed by
Tukey’s post hoc test, as appropriate. Significance was
set at P < 0.05.Results
Inhibition of the P2X3 receptor suppresses NP-induced
pain hypersensitivity
Implantation of autologous nucleus pulposus (NP) har-
vested from the rat tail to the lumbar 5 and lumbar 6
spinal nerve roots produced pain hypersensitivity in
rats when compared with sham rats. In the NP-treated
group, mechanical paw withdrawal threshold (PWT)
decreased significantly on the ipsilateral side 3 days
after surgery, indicating ipsilateral mechanical allody-
nia. This change persisted through day 28, and returned
to baseline level on day 35 after implantation (*P < 0.05,
Figure 1A). Compared to the sham group, the NP-treated
rats showed a dramatic increase in body weight bearing
difference. The body weight bearing difference was in-
creased on day 3 after NP application, and returned to
baseline level on day 35 after NP application (*P < 0.05,
Figure 1B). To determine whether surgery had an effect on
motor performance, Rota rod tests were performed in this
study. There was no significant difference in the time that
rats remained on the bar rotating at a fixed-speed (20 rpm)
between the LDH and sham groups (Figure 1C, P > 0.05).
A-317491 was used to determine whether P2X3 recep-
tors are involved in the development of allodynia in NP-
treated rats. A-317491 has been shown to have a high
affinity and selectivity for blocking P2X3 homomeric
and P2X2/3 heteromeric receptor channels and to pro-
duce antinociception in rat models of chronic inflamma-
tory and neuropathic pain [41]. A single intrathecal
injection of A317491 produced an antinociceptive effect
on PWT and weight bearing in LDH rats (n = 8 for each
group, Friedman ANOVA). Injection of A-317491 at
doses of 10 nmol did not produce a significant effect on
PWT (Figure 1D) and body weight bearing (Figure 1E).
However, injection of A-317491 at 30,100 or 300 nmol
markedly increased PWT and reduced the body weight
bearing difference. The PWTs were markedly increased
at 30 min, which lasted for 2 hours after the A-317491
injection, when compared to the NS group (Figure 1D,
*P < 0.05, **P < 0.01, n = 8 for each group, Kruskal-
Wallis ANOVA followed by Tukey’s post hoc test). The
body weight bearing difference was also remarkably de-
creased at 30 min and lasted for 2 hours after A-317491
injection when compared to the NS group (Figure 1E,
*P < 0.05, n = 8 for each group, Tukey’s post hoc test
following Kruskal–Wallis ANOVA). In contrast, injection
of A-317491 at a dose of 100 nmol did not produce any ef-
fect on PWTs in age-matched healthy control rats (n = 5,
Figure 1F). The effect of A317491 on motor activity in the
LDH rats was determined using the Rota rod test. There
was no significant difference in the time that rats
remained on the bar rotating at a fixed-speed (20 rpm) be-
fore (Pre) and after (Post) injection of A317491 (Figure 1G,
paired sample t-test, P > 0.05, n = 8 rats).
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To determine the mechanism underlying the NP-
induced mechanical allodynia, the expression levels of
P2X3Rs in lumber DRGs were analyzed. Proteins were
extracted from L5-6 DRGs of rats at 3, 7 and 35 days
after NP-application or sham surgery. At 3 days after NP
application, P2X3R protein expression was significantly
increased after NP-treatment (Figure 2A, *P < 0.05, two
sample t-test). The relative densitometry was 1.67 ± 0.30
(n = 6) in the NP-treated group and 0.72 ± 0.05 (n = 6)
in the sham group. At 7 days after NP application,
P2X3R protein expression was markedly increased after
NP-treatment (Figure 2B, *P < 0.05, two sample t-test).
The relative densitometry was 1.38 ± 0.20 (n = 6) in the
NP-treated group and 0.75 ± 0.07 (n = 6) in the shamFigure 2 Increased expression of P2X3 receptors in LDH rats. (A) Expr
NP application when compared to the sham group (n = 6 for each group,
was remarkably enhanced 7 days after NP application when compared to t
(C) Expression of P2X3Rs in L5-6 DRGs was not altered 35 days after NP ap
P > 0.05, two sample t-test). (D) There were no significant differences in P2
(n = 6 for each group). (E) NP application did not alter the expression of P
for each group, P > 0.05, two sample t-test). (F) NP application did not alte
the sham group (n = 6 for each group, P > 0.05, two sample t-test). A GAPgroup. At 35 days after NP application, P2X3R protein
expression was not altered after NP-treatment (Figure 2C,
P > 0.05, two sample t-test). The relative densitometry was
1.09 ± 0.03 (n = 6) in the NP-treated group and 1.01 ±
0.04 (n = 6) in the sham group. To confirm the specificity,
expression of P2X3 receptors in thoracic DRGs was deter-
mined. There were no significant differences in the ex-
pression of P2X3 receptors in T10-12 DRGs between the
sham and LDH groups (Figure 2D, P > 0.05). The relative
densitometry was 1.21 ± 0.13 (n = 6) in the NP-treated
T10-T12 DRGs and 1.29 ± 0.15 (n = 6) in T10-T12 DRGs
of the sham group. We also examined the expression of
other subtypes of purinergic receptors. The relative densi-
tometry of P2X1 receptors was 1.02 ± 0.06 (n = 6) in the
NP-treated L5-6 DRGs and 0.98 ± 0.06 (n = 6) in L5-6ession of P2X3Rs in L5-6 DRGs was significantly enhanced 3 days after
*P < 0.05, two sample t-test). (B) Expression of P2X3Rs in L5-6 DRGs
he sham group (n = 6 for each group, *P < 0.05, two sample t-test).
plication when compared to the sham group (n = 6 for each group,
X3R expression in T10-12 DRGs between the sham and LDH groups
2X1 receptors in L5-6 DRGs when compared to the sham group (n = 6
r the expression of P2X2 receptors in L5-6 DRGs when compared to
DH control for each sample was used as a loading control.
Wang et al. Molecular Pain  (2015) 11:15 Page 7 of 13DRGs of the sham group. The relative densitometry of
P2X2 receptor was 0.60 ± 0.08 (n = 6) in the NP-treated
L5-6 DRGs and 0.58 ± 0.08 (n = 6) in L5-6 DRGs of the
sham group. The expression of P2X1 and P2X2 receptors
was not altered significantly 7 days after NP-treatment
when compared to sham rats (Figure 2E and F, P > 0.05,
two sample t-test).
NP-application potentiates ATP-induced calcium signals
We next examined whether NP-application enhances
ATP-induced responses in DRG neurons labeled by DiI.
Only small and medium cells (25 to 35 μm in diameter),
which are known to mediate the transmission of noci-
ceptive signals [42], were used in the present study. We
first examined the effect of NP-application on ATP-evoked
calcium mobilization. As described above, L5-6 DRG neu-
rons were labeled by DiI (Figure 3A, arrows). Application
of ATP at a concentration of 20 μM elicited significantly
larger calcium signals in NP treated animals than in shamFigure 3 Potentiation of ATP-induced intracellular calcium mobilizatio
images of DRG neurons. A hindpaw innervating DRG neuron is shown in re
calcium signals in a DiI-labeled DRG neuron from a sham (upper) and LDH
transients in hindpaw innervating DRG neurons. NP application significantly
compared to the sham group (sham, n = 46 cells, LDH, n = 46 cells, *P < 0
ATP application was not significantly altered in LDH rats when compared t
LDH group, P > 0.05, χ2 test).rats (Figure 3B and C, n = 46 cells for each group). In con-
trast, the percentage of numbers of neurons responding to
ATP application was not significantly altered in LDH rats
when compared to sham rats (Figure 3D). The percentage
of numbers of neurons was 82.5% and 84.4% for sham
group and LDH group, respectively.
Inhibition of CBS activity reverses expression and
function of P2X3Rs
We next determined the mechanisms underlying the
sensitization of P2X3 receptors (P2X3Rs) under the
LDH condition. Since we have previously shown that the
endogenous H2S producing enzyme cystathionine-β-
synthetase (CBS) plays a role in inflammatory pain and
visceral pain conditions [11,17,34,43], we determined
whether sensitization of P2X3Rs is regulated by en-
dogenous H2S signaling. We first examined whether
P2X3Rs were co-localized with CBS in DiI labeled DRG
neurons. Triple-labeling techniques showed that 4 neuronsn in LDH rats. (A) Bright-field (upper) and DiI-fluorescence (lower)
d (arrow). Bar = 50 μm. (B) An example trace of ATP (20 μM) -induced
(lower) rat. (C) Bar graph showing a potentiation of ATP-induced Ca2+
enhanced ATP-induced Ca2+ transients of L5-6 DRG neurons when
.05, two sample t-test). (D) The percentage of neurons responding to
o sham rats (n = 80 cells for the sham group and n = 90 cells for the
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were also positive for CBS (Figure 4). Similarly, 4 neurons
that were immunoreactive for CBS were also positive for
P2X3 receptors (Figure 4). These data indicate that P2X3Rs
are co-expressed with CBS in hindpaw innervating DRG
neurons.
P2X3 receptor expression was then measured after
treatment with AOAA. AOAA at 10 μg/kg body weight
(once every day for 7 consecutive days) was used since this
dose significantly attenuated the pain behavior. AOAA
intrathecal injection remarkably reversed the expression of
P2X3R in DRGs from LDH rats when compared to the
NS group. The relative densitometry of P2X3R was 2.60 ±
0.24 (n = 7) for the NS group and 1.35 ± 0.17 (n = 7) for
the AOAA group (Figure 5A, *P < 0.05, two sample t-test).
In addition, AOAA treatment significantly reduced the
ATP-evoked intracellular calcium mobilization when
compared with NS treatment in LDH rats (Figure 5B,
*P < 0.05, n = 48 cells for the NS group, n = 56 cells for
the AOAA group, two sample t-test). In contrast, the
percentage of neurons responding to ATP application
was not significantly altered in AOAA-treated rats when
compared with NS-treated rats (Figure 5C).
Furthermore, expression of CBS in L5-6 DRGs was ex-
amined after NP application. NP application markedly
increased the expression of CBS when compared to the
sham group. The relative densitometry was 1.00 ± 0.03
(n = 7) in the NP-treated group and 0.65 ± 0.05 (n = 7)
in the sham group (Figure 5D, *P < 0.05, two sampleFigure 4 Co-expression of CBS with P2X3 receptors in hindpaw innervatin
with DiI (red) injected into the hindpaw. (B) P2X3R positive cells are shown in
labeling of DiI and P2X3Rs in DRGs. (E) Merge of CBS-positive staining and Dit-test). There were no significant differences in CBS ex-
pression in T10-12 DRGs between the sham and LDH
groups. The relative densitometry was 1.09 ± 0.15 (n = 6)
in the NP-treated group and 1.09 ± 0.15 (n = 6) in the
sham group (Figure 5E, P > 0.05, two sample t-test). We
also investigated the expression of cystathionine-γ-lyase
(CSE), another endogenous H2S producing enzyme. The
expression of CSE in L5-6 DRGs was not altered signi-
ficantly 7 days after NP application when compared to
sham rats. The relative densitometry was 0.81 ± 0.09 (n = 6)
in the NP-treated group and 0.86 ± 0.06 (n = 6) in the
sham group (Figure 5F, P > 0.05, two sample t-test).
Intrathecal administration of CBS inhibitor attenuates
NP-induced pain hypersensitivity
We then determined whether CBS is involved in the
development of pain hypersensitivity in LDH rats. We
observed the acute and chronic effects of the CBS
inhibitor AOAA on PWT and body weight bearing
difference in LDH rats. One day after NP application, a
total of 26 LDH rats were intrathecally administered
AOAA at different doses (0.1, 1.0, 10.0 and 100.0 μg/kg
body weight) in a volume of 10 μl. PWT and body
weight bearing differences were recorded from LDH rats
30 min after a single injection of AOAA. NS and AOAA
at the lower doses (0.1 μg/kg) had no significant effect
on the PWT and body weight bearing tests. However,
AOAA at 1, 10 and 100 μg/kg produced a significant in-
crease in PWT (Figure 6A, n = 6, 6, 7, 7 and 5 for theg DRG neurons. (A) L5 DRG cells innervating the hindpaw were labeled
blue. (C) CBS positive cells are shown in green. (D) Merge of double
I labeling. (F) Merge of CBS staining and P2X3R labeling. Bar = 50 μm.
Figure 5 Antagonism of the CBS inhibitor on the expression and function of P2X3 receptors. (A) Administration of the CBS inhibitor
O-(carboxymethyl) hydroxylamine hemihydrochloride (AOAA, 10 μg/kg) significantly reduced the expression of P2X3Rs in L5–L6 DRGs from LDH
rats (*P < 0.05, n = 7 for each group). (B) In LDH rats, application of AOAA greatly reduced the ATP-evoked intracellular calcium mobilization
when compared to NS-treated rats (NS, n = 48 cells, LDH, n = 56 cells, *P < 0.05, two sample t-test). (C) The percentage of neurons responding
to ATP application was not significantly altered in LDH rats when compared to sham rats (n = 96 cells for each group, P > 0.05, χ2 test). (D) LDH
treatment significantly enhanced expression of CBS in L5–L6 DRGs when compared to sham rats (n = 7 for each group, *P < 0.05). (E) There was
no significant difference in CBS expression in T10-12 DRGs between the sham and LDH groups (n = 6 for each group). (F) There was no significant
difference in CSE expression in L5-6 DRGs between the sham and LDH groups (n = 6 for each group).
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10.0 and 100.0 μg/kg, respectively, **P < 0.01, compared
to the NS group, Kruskal-Wallis ANOVA followed by
Tukey’s post hoc test). The antinociceptive effect
returned to baseline level at 1 hour after injection of
AOAA. Similarly, a single injection of AOAA signifi-
cantly reduced the body weight bearing difference in
LDH rats, starting 30 min after injection and returning
to baseline level one hour after injection (Figure 6B,
n = 6 for each group, *P < 0.01, compared to the NS
group; Kruskal-Wallis ANOVA followed by Tukey’s post
hoc test). To further determine the antinociceptive effect
of the CBS inhibitor, AOAA at 10 μg/kg was administeredintrathecally once daily for 7 consecutive days. PWTs
and body weight bearing tests were performed 30 min
after the last injection of AOAA and continued to be mea-
sured for 48 hours. As expected, multiple injections of
AOAA at 10 μg/kg produced a dramatic antinociceptive
effect on both the PWT and body weight bearing dif-
ference, lasting for at least 24 hours (Figure 6C and D,
n = 7 rats for each group, *P < 0.01, Friedman ANOVA).
Single or multiple injections of AOAA at 10 μg/kg did
not produce a significant effect on the time that rats
remained on the Rota rod bar when compared with Pre
injection performance (Figure 6E and F, n = 8 rats for
each group, P > 0.05).
Figure 6 Antagonism of intrathecal injection of CBS inhibitor on LDH-induced pain hypersensitivity. (A) A single intrathecal injection of
the CBS inhibitor AOAA attenuated mechanical allodynia induced by LDH. The maximal effect occurred at a dose of 10 μg/kg body weight in the
present study. The AOAA-induced antinociceptive effect dissipated 1 hour after injection. n = 8 for each group, *P < 0.05 compared to Pre injection
values. (B) A single intrathecal injection of the CBS inhibitor AOAA reduced the body weight bearing difference induced by LDH. The maximal effect
occurred at a dose of 10 μg/kg body weight. The AOAA-induced antinociceptive effect dissipated 1 hour after injection. n = 6 for each group,
*P < 0.05 compared to NS. (C) Chronic effects of AOAA injection (10 μg/kg, once every day for 7 consecutive days) on mechanical withdrawal
threshold. Multiple injections of AOAA attenuated PWT, which lasted for 24 hours after injection. *P < 0.05 versus NS, n = 8 for each group.
(D) Multiple injections of AOAA reduced the body weight bearing difference, which lasted for 24 hours after injection. *P < 0.05 versus NS, n = 7 for
each group. (E) A single intrathecal injection of AOAA did not produce any effect on the time that rats remained on the bar during the Rota rod test.
(F) Multiple intrathecal injections of AOAA did not produce any effect on the time that rats remained on the bar during the Rota rod test.
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NP-induced pain hypersensitivity and the expression of
P2X3 receptors
We then determined whether peripheral CBS is involved
in the development of pain hypersensitivity in LDH rats.
We observed the acute and chronic effects of AOAA
injected into the hindpaw on PWT and body weight bear-
ing difference in LDH rats. As shown in Figure 7, neither
a single injection (Figure 7A and B, n = 6 for each group)
nor multiple injection (Figure 7C and D, n = 6 for each
group) of AOAA produced significant effects on PWT
(Figure 7A and C) and BWD (Figure 7B and D) of LDH
rats. In addition, multiple injection of AOAA into hind-
paw did not significantly alter the expression of P2X3
receptors of LDH rats (Figure 7E, n = 4). These data sug-
gest that CBS at peripheral tissues might not play a role in
the development of LDH induced pain hypersensitivity.Discussion
The present study demonstrated that autologous NP ap-
plication to the spinal nerve produced a prolonged mech-
anical allodynia accompanied by reduced body weight
bearing by the affected limb, suggesting that it was painful
to place full weight on the hindpaw. In addition, we
showed for the first time that these behaviors were corre-
lated with increased expression of P2X3 receptor proteins
and the endogenous hydrogen sulfide producing enzyme
CBS in the corresponding DRGs. Importantly, spinal in-
hibition of P2X3Rs by A317491 or CBS by AOAA during
the maintenance phase attenuated NP-induced discogenic
pain hypersensitivity. However, hindpaw injection of
AOAA did not alter the pain hypersensitivity in LDH rats.
These results suggest that CBS-H2S and purinergic signal-
ing pathways at spinal level are involved in NP-induced
peripheral discogenic pain hypersensitivity in rats.
Figure 7 Antagonism of hindpaw injection of CBS inhibitor on LDH-induced pain hypersensitivity. (A) A single hindpaw injection of the
CBS inhibitor AOAA at different doses (3, 6 and 9 mg/kg body weight) did not significantly alter mechanical allodynia induced by LDH. (B) A
single hindpaw injection of the CBS inhibitor AOAA did not alter the body weight bearing difference induced by LDH. (C) Chronic effects of
AOAA injection (9 mg/kg body weight, once every day for 7 consecutive days) did not altered mechanical withdrawal threshold. (D) Multiple
injections of AOAA did not alter the body weight bearing difference. (E) Multiple hindpaw injections of AOAA did not affect protein levels of
P2X3 receptor of LDH rats (n = 4 for each group).
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to target both the spinal cells and the DRG cells
[37,38,44-47]. Here, intrathecal injection of a P2X3R
antagonist may inhibit the P2X3 receptors in both the
spinal cord and DRGs. In parallel with the increased
expression of P2X3 receptors in DRGs, our behavioral
data showed that inhibition of the P2X3R by intrathecal
injection of A317491 markedly enhanced the paw with-
drawal threshold and reduced the body weight bearing
difference at 7 days after NP application. Additionally, it
was reported that local or systematic administration of a
P2X3R antagonist reversed the mechanical allodynia in
rats treated with streptozotocin- [14] or cancer cells
[48-50]. Inhibition of P2X receptors also attenuated the
visceral hypersensitivity induced by neonatal colonic
inflammation [11], suggesting that P2X receptors con-
tribute to the maintenance of the various chronic pain
conditions. Of note is that the prolonged duration of
AOAA effect observed in the present study would bedue to the central effect since the intrathecally admi-
nistered drugs might have wide access to the central
nervous system shortly after administration. This needs
to be further investigated.
The upregulation of P2X3R expression in L5 and L6
DRGs is consistent with our previous report [51] and
supported by calcium imaging studies showing that NP
application enhanced ATP-induced intracellular calcium
mobilization of DRG neurons innervating the hindpaw.
In the present study, we also observed that the expres-
sion level of P2X3Rs was well correlated with changes
in pain hypersensitivity in rats after NP application.
However, P2X1 and P2X2 receptor expression was not
altered after NP application. In addition, expression of
P2X3 receptors was not altered in thoracic DRGs (e.g.,
T10-12) after NP application. These data suggest a spe-
cific role for P2X3Rs in a rat model of LDH in terms of
expression, and that upregulation of P2X3Rs in corre-
sponding DRGs is not a non-specific effect after NP
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in physiological [52] and various pathophysiological
pain conditions, including inflammatory pain [10,53],
neuropathic pain [54,55], visceral pain [11] and cancer
pain [48,50]. However, the molecular mechanisms
underlying the upregulation of P2C receptors remain
largely unknown.
In the present study, we showed that P2X3Rs was
colocalized with CBS in hindpaw innervating DRG neu-
rons, suggesting a possible interaction between P2X3Rs
and CBS in DRG neurons. The results of western blot
analysis further confirmed that an increase in P2X3R ex-
pression was regulated by CBS activity in the DRGs,
since inhibition of CBS activity reversed the upregulation
of P2X3Rs. This evidence supports that P2X3Rs and
CBS may be involved in neuropathic pain at DRG levels.
Importantly, CBS upregulation was only observed in L5
and L6 DRGs rather than in nearby DRGs (e.g., T10 ~ 12
DRGs). In addition, expression of CSE, another H2S
producing enzyme, was not changed in the DRGs after
NP application. Taken together, these results support the
idea that CBS may play an important role in the regulation
of P2X3R expression and function under pathophysio-
logical conditions. It has been demonstrated that hydrogen
sulfide (H2S) can regulate neuronal excitability by regulat-
ing voltage-gated sodium channels [35,36,56], voltage-
gated potassium channels [39] and voltage-gated calcium
channels [57], thus contributing to the development of
chronic pain hypersensitivity. Here, we added evidence to
show that P2X3R expression and function is regulated by
CBS activity. Although we only examined CBS expression
in the DRGs, other modulators, such as proinflammatory
cytokines, chemokines, and nerve growth factors, may also
increase and contribute to NP-induced pain hypersensitiv-
ity. In addition, the detailed mechanisms underlying the
regulation of P2X3R activities by CBS activation need to
be further investigated.
In summary, the present study demonstrates for the
first time that the expression of P2X3Rs and CBS is
significantly enhanced in DRGs after NP application,
and that intrathecal administration of a CBS antagonist
remarkably attenuates the pain hypersensitivity in a rat
model of LDH. Our findings suggest that the increased
CBS expression may mediate NP-induced pathological
changes by increasing P2X3R expression and function in
the DRG neurons. The targeting of CBS/H2S signaling
may be a potential treatment strategy for chronic radicu-
lar neuropathic pain.
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